Related Experiment Video
Updated: Apr 11, 2026

Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
Published on: March 5, 2020
Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
Laura Sartiani1, Maria Novella Romanelli, Alessandro Mugelli
1Department of NeuroFarBa, C.I.M.M.B.A., University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy. laura.sartiani@unifi.it.
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are crucial for heart rhythm. Dysfunction in these cardiac channels can cause arrhythmias, but blockade with ivabradine shows therapeutic potential.
Area of Science:
- Cardiovascular physiology
- Molecular cardiology
- Ion channel research
Background:
- Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are key to cardiac pacemaker activity.
- HCN channels are present in various cardiac cells, with roles in adult cardiomyocytes under investigation.
- Channel dysfunction is implicated in cardiac rhythm disorders.
Purpose of the Study:
- To investigate the role of HCN channels in cardiac function and pathology.
- To explore the therapeutic potential of modulating HCN channel activity.
Main Methods:
- Review of literature on HCN channel function in cardiac physiology and pathology.
- Analysis of clinical and experimental data regarding HCN channel mutations and pharmacological interventions.
Main Results:
- Loss-of-function mutations in HCN channels are linked to sinus bradycardia.
- Gain-of-function in HCN channels may promote arrhythmias like atrial fibrillation and ventricular hypertrophy.
- Ivabradine, an HCN channel blocker, improves cardiac performance and outcomes in heart failure.
Conclusions:
- HCN channels are critical determinants of cardiac rhythm.
- Targeting HCN channels, particularly with ivabradine, offers a promising therapeutic strategy for cardiac arrhythmias and heart failure.
- Development of novel, selective HCN channel modulators is ongoing.
More Related Videos
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Heart Failure Drugs: Inotropic Agents
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...